Hypertension
Showing NaN - NaN of 84
Hypertension Trial in Cincinnati (baxdrostat (formerly CIN-107) oral solution)
Completed
- Hypertension
- baxdrostat (formerly CIN-107) oral solution
-
Cincinnati, OhioMedpace
Jul 18, 2023
Hypertension Trial in United States (Anti-hypertensive therapy, No anti-hypertensive therapy (unless BP is severe))
Completed
- Hypertension
- Anti-hypertensive therapy
- No anti-hypertensive therapy (unless BP is severe)
-
Birmingham, Alabama
- +71 more
Dec 16, 2022
Hypertension Trial in Cincinnati (CIN-107, Matching Placebo)
Completed
- Hypertension
- CIN-107
- Matching Placebo
-
Cincinnati, OhioMedpace Clinical Pharmacology Unit
Aug 12, 2022
Samples From Pregnant Evaluation of Preeclampsia Biomarkers
Completed
- Preeclampsia
- +6 more
-
Birmingham, Alabama
- +19 more
Mar 10, 2022
Obesity, Hypertension, Hyperlipidemias Trial in Cincinnati (In-store POP education, Online POP education)
Completed
- Obesity
- +3 more
- In-store POP education
- Online POP education
-
Cincinnati, OhioUniversity of Cincinnati Medical Center - UC Health
Feb 18, 2022
HIV, Cardiovascular Diseases, Hypertension Trial in United States (Indinavir sulfate, Ritonavir, Amlodipine)
Completed
- HIV Infections
- +2 more
- Indinavir sulfate
- +3 more
-
San Francisco, California
- +8 more
Oct 28, 2021
Hypertension Trial in United States (, PF-00489791)
Hypertension, Resistant Hypertension Trial in Worldwide (MobiusHD, Sham Implantation)
Active, not recruiting
- Hypertension
- Resistant Hypertension
- MobiusHD
- Sham Implantation
-
Birmingham, Alabama
- +23 more
Oct 4, 2021
Dyslipidemia, Hypertension Trial in United States (Amlodipine besylate, Amlodipine besylate/atorvastatin calcium single pill
Completed
- Dyslipidemia
- Hypertension
- Amlodipine besylate
- Amlodipine besylate/atorvastatin calcium single pill combination
-
Birmingham, Alabama
- +50 more
Jan 26, 2021
Hypertension, Dyslipidemia Trial in United States (Amlodipine/Atorvastatin)
Completed
- Hypertension
- Dyslipidemia
-
Birmingham, Alabama
- +105 more
Jan 26, 2021
Dyspnea, Hypertension, Acute Heart Failure Trial in United States (Stage 1: Clevidipine (double-blinded), Stage 1: Placebo
Withdrawn
- Dyspnea
- +2 more
- Stage 1: Clevidipine (double-blinded)
- +3 more
-
Montgomery, Alabama
- +8 more
Oct 12, 2020
Hypertension Trial in United States (Nebivolol with concomitant losartan or lisinopril, HCTZ with concomitant losartan or
Completed
- Hypertension
- Nebivolol with concomitant losartan or lisinopril
- +2 more
-
Athens, Alabama
- +87 more
Feb 13, 2020
Preeclampsia (Pre-E) Biomarkers From Pregnant Women
Unknown status
- Pre-Eclampsia
- +8 more
- Non-interventional study
-
San Diego, California
- +23 more
Jan 22, 2020
Hypertension Trial in Dominican Republic, United States (metoprolol succinate)
Completed
- Hypertension
- metoprolol succinate
-
Little Rock, Arkansas
- +30 more
Jan 14, 2020
Understudied Drugs Administered to Children Per Standard of Care
Completed
- Adenovirus
- +58 more
- The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:
-
Anchorage, Alaska
- +51 more
Dec 18, 2019
Hypertension, High Blood Pressure Trial in United States (ROX Coupler, Sham procedure)
Terminated
- Hypertension
- High Blood Pressure
- ROX Coupler
- Sham procedure
-
Birmingham, Alabama
- +12 more
May 9, 2019
Hypercholesterolemia, Hypertension Trial in United States (ETC-1002, Placebo)
Completed
- Hypercholesterolemia
- Hypertension
- ETC-1002
- Placebo
-
Birmingham, Alabama
- +34 more
Mar 26, 2019
Hypertension Trial in Puerto Rico, United States (Olmesartan medoxomil, Amlodipine, Hydrochlorothiazide)
Completed
- Hypertension
- Olmesartan medoxomil
- +2 more
-
Birmingham, Alabama
- +231 more
Dec 20, 2018
Hypertension Trial in United States (amlodipine and olmesartan medoxomil tablets, hydrochlorothiazide tablets)
Completed
- Hypertension
- amlodipine and olmesartan medoxomil tablets
- hydrochlorothiazide tablets
-
Birmingham, Alabama
- +71 more
Dec 20, 2018
Hypertension Trial in United States (olmesartan medoxomil + hydrochlorothiazide, if necessary, Placebo)
Completed
- Hypertension
- olmesartan medoxomil + hydrochlorothiazide, if necessary
- Placebo
-
Birmingham, Alabama
- +28 more
Sep 4, 2018
Hypertension Trial in Canada, Puerto Rico, United States (Carvedilol Phosphate modified release formulation, metoprolol
Completed
- Hypertension
- Carvedilol Phosphate modified release formulation
- metoprolol succinate
-
Birmingham, Alabama
- +119 more
Mar 19, 2018